Tag:
Diartis
Latest Headlines
Latest Headlines
Versartis grabs $21M Series B, aims to begin study of once-monthly hormone therapy
Investors have injected a $21 million second round of venture money into Versartis, a company that focuses on long-acting release treatments for endocrine disorders. With the new round, the Mountain
